3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice. 2020

Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
Department of Chemistry, Wichita State University, Wichita, KS 67260, USA.

Pathogenic coronaviruses are a major threat to global public health, as exemplified by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and the newly emerged SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19). We describe herein the structure-guided optimization of a series of inhibitors of the coronavirus 3C-like protease (3CLpro), an enzyme essential for viral replication. The optimized compounds were effective against several human coronaviruses including MERS-CoV, SARS-CoV, and SARS-CoV-2 in an enzyme assay and in cell-based assays using Huh-7 and Vero E6 cell lines. Two selected compounds showed antiviral effects against SARS-CoV-2 in cultured primary human airway epithelial cells. In a mouse model of MERS-CoV infection, administration of a lead compound 1 day after virus infection increased survival from 0 to 100% and reduced lung viral titers and lung histopathology. These results suggest that this series of compounds has the potential to be developed further as antiviral drugs against human coronaviruses.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.

Related Publications

Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
December 2019, Chemical biology & drug design,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
July 2016, Bioorganic & medicinal chemistry,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
August 2013, Recent patents on anti-infective drug discovery,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
January 2019, Current computer-aided drug design,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
May 2023, European journal of medicinal chemistry,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
March 2022, Chemical & pharmaceutical bulletin,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
January 2010, Expert opinion on therapeutic patents,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
June 2006, Journal of medicinal chemistry,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
July 2021, Computers in biology and medicine,
Athri D Rathnayake, and Jian Zheng, and Yunjeong Kim, and Krishani Dinali Perera, and Samantha Mackin, and David K Meyerholz, and Maithri M Kashipathy, and Kevin P Battaile, and Scott Lovell, and Stanley Perlman, and William C Groutas, and Kyeong-Ok Chang
August 2020, Microorganisms,
Copied contents to your clipboard!